快速的尿液代谢量,用于评估佐皮克隆对失眠的影响
Jun Li1, Yang Zhao2, Guifang Liu2
1Inspection Department, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
Journal of pharmacological and toxicological methods
|May 10, 2025
概括
这项研究开发了一种尿液代谢学方法,用于预测失眠患者对佐皮克隆敏感性的预测. 某些特定的代谢物,如GHB,瓦林和异黄素,可以作为个性化失眠治疗的生物标志物.
科学领域:
- 代谢学 代谢学 代谢学
- 临床化学 临床化学
- 药物基因组学 药物基因组学
背景情况:
- 失眠是一种与神经退行性疾病相关的常见症状,通常用佐皮克隆治疗.
- 患者对佐皮克隆的反应各不相同,不清楚的机制阻碍了有效的治疗方案.
- 开发预测佐皮克隆敏感性的方法对于优化失眠治疗至关重要.
研究的目的:
- 开发一种快速的尿液代谢学方法,用于评估在失眠患者中佐皮克隆的敏感性.
- 为了确定潜在的代谢生物标志物,表明佐皮克隆治疗反应.
- 引导个性化治疗策略用于失眠管理.
主要方法:
- 使用不同的甲醇-水比率进行尿液代谢组提取,然后进行LC-MS分析.
- 优化尿液提取以进行增强的代谢组分析.
- 应用开发的方法来比较Zopiclone敏感和不敏感的失眠患者的尿液代谢.
主要成果:
- 确定了一种最佳的尿液提取方法,其中尿液:甲醇:水的比例为1:1:3.
- 在患者组之间观察到乙卡尼丁,β-基酸 (BHB),4-基酸 (GHB) 和氨基酸的显著差异.
- GHB,瓦林和异黄素水平的变化与匹兹堡睡眠质量指数 (PSQI) 分数相关.
结论:
- 开发的尿液代谢学方法有效地区分了Zopiclone对失眠患者的敏感性.
- 特定的代谢物包括GHB,瓦林和异黄素显示出作为预测佐皮克隆反应的生物标志物的潜力.
- 这些发现可以为失眠的个性化治疗调整提供信息,改善治疗结果.
相关概念视频
Management of Insomnia
207
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
207
Sedatives and Hypnotics Drugs: Miscellaneous Agents
119
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
119
Sedatives and Hypnotics Drugs: Benzodiazepines
138
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
138
Sedatives and Hypnotics: Overview
225
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
225
CNS Depressants: Barbiturates and Benzodiazepines
170
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
170
Sedatives and Hypnotics Drugs: Barbiturates
144
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
144


